Dimensional Fund Advisors LP Bei Gene, Ltd. Transaction History

Dimensional Fund Advisors LP

$403 Billion
Q3 2024

A detailed history of Dimensional Fund Advisors LP transactions in Bei Gene, Ltd. stock. As of the latest transaction made, Dimensional Fund Advisors LP holds 21,015 shares of BGNE stock, worth $3.88 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

21,015

Previous 11,499 82.76%

Holding current value

$3.88 Million

Previous $1.64 Million 187.68%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 07, 2024	BUY	$143.93 - $224.51 $1.37 Million - $2.14 Million	9,516 Added 82.76%	21,015 $4.72 Million
Q2 2024 Aug 09, 2024	BUY	$129.52 - $174.32 $808,981 - $1.09 Million	6,246 Added 118.9%	11,499 $1.64 Million
Q1 2024 May 10, 2024	SELL	$141.8 - $181.47 $855,904 - $1.1 Million	-6,036 Reduced 53.47%	5,253 $821,000
Q4 2023 Feb 07, 2024	SELL	$158.67 - $201.58 $30,940 - $39,308	-195 Reduced 1.7%	11,289 $2.04 Million
Q3 2023 Nov 09, 2023	SELL	$179.87 - $225.13 $127,707 - $159,842	-710 Reduced 5.82%	11,484 $2.07 Million
Q2 2023 Aug 09, 2023	SELL	$178.3 - $266.78 $49,032 - $73,364	-275 Reduced 2.21%	12,194 $2.17 Million
Q1 2023 May 12, 2023	SELL	$215.53 - $274.5 $104,316 - $132,858	-484 Reduced 3.74%	12,469 $2.69 Million
Q4 2022 Feb 09, 2023	SELL	$125.51 - $229.3 $170,944 - $312,306	-1,362 Reduced 9.51%	12,953 $2.85 Million
Q3 2022 Nov 10, 2022	SELL	$131.8 - $202.24 $122,310 - $187,678	-928 Reduced 6.09%	14,315 $1.93 Million
Q2 2022 Aug 12, 2022	SELL	$121.11 - $216.05 $15,138 - $27,006	-125 Reduced 0.81%	15,243 $2.46 Million
Q1 2022 May 13, 2022	BUY	$146.52 - $269.56 $299,926 - $551,789	2,047 Added 15.37%	15,368 $2.94 Million
Q4 2021 Feb 09, 2022	SELL	$248.56 - $389.34 $50,209 - $78,646	-202 Reduced 1.49%	13,321 $3.61 Million
Q3 2021 Nov 12, 2021	SELL	$249.6 - $403.14 $1.73 Million - $2.79 Million	-6,919 Reduced 33.85%	13,523 $4.91 Million
Q2 2021 Aug 12, 2021	SELL	$292.75 - $367.01 $938,849 - $1.18 Million	-3,207 Reduced 13.56%	20,442 $7.06 Million
Q1 2021 May 14, 2021	BUY	$260.64 - $382.12 $107,383 - $157,433	412 Added 1.77%	23,649 $8.16 Million
Q4 2020 Feb 25, 2021	BUY	$221.31 - $316.61 $5.14 Million - $7.36 Million	23,237 New	23,237 $5.99 Million

Others Institutions Holding BGNE

# of Institutions

252

Shares Held

45.3M

Call Options Held

292K

Put Options Held

119K

View Full List

About BeiGene, Ltd.

Ticker BGNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 103,700,000
Market Cap $19.2B
Description
BeiGene, Ltd., a biotechnology company, focuses on discovering, developing, manufacturing, and commercializing various medicines worldwide. Its products include BRUKINSA to treat relapsed/refractory (R/R) mantle cell lymphoma; Tislelizumab to treat R/R classical Hodgkin's lymphoma; REVLIMID to treat multiple myeloma; VIDAZA to treat myelodysplas...

More about BGNE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Dimensional Fund Advisors LP with notifications on news.

Account

Dimensional Fund Advisors LP Bei Gene, Ltd. Transaction History